A bill to lower the price of insulin drugs and supplies for more North Dakotans attracted passionate discussion at a Thursday ...

If adopted as currently written, House Bill 1114 would set out-of-pocket costs for a monthly supply of insulin at $25 for the North Dakota commercial insurance market. Under state law, however, North ...

House Bill 1114 would set out-of-pocket costs for a monthly supply of insulin at $25 for the North Dakota commercial ...

Israel-headquartered Oramed Pharmaceutical is developing its own oral insulin ORMD-0801, and presented data from a phase 2b trial in San Diego. Other companies are looking to administer insulin ...

Lawmakers in North Dakota will hear testimony on a bill that would lower the price of insulin drugs and supplies on Thursday.

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

A study comparing oral glucose-lowering agents to insulin for gestational diabetes found no non-inferiority in preventing ...

Insulin has long been the typical pharmacological go-to agent for gestational diabetes, the researchers pointed out, but oral ...